Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
U.S. stock index futures tied to the S&P 500 hit an all-time high on Wednesday, propelled by a surge in cloud computing firm Oracle, as investors awaited producer prices data due later in the day for insights into U.S. inflation. .N
** Baidu Inc :
BUZZ - HK stock hits 11-month peak on release of updated AI reasoning model nL2N3UX03Q
** SAP SE :
BUZZ - Shares up in early trade after Oracle boosts 2026 cloud outlook nL6N3UX0B6
** Apple Inc
BUZZ - Shares slip after no price rise on new iPhones, other devices nL6N3UX0FK
** Nike Inc
BUZZ - Rises after TD Cowen upgrades to 'buy' nL6N3UX0GU
** Oracle Corp :
** Nvidia Corp :
** Advanced Micro Devices Inc :
** Broadcom Inc :
BUZZ - US chipmakers' shares up as Oracle expects $500 billion in booked cloud orders nL3N3UX0LW
** GameStop Corp
BUZZ - Rises after strong quarterly revenue nL3N3UX0MF
** Vistra Corp :
** Constellation Energy Corp :
** GE Vernova Inc :
** NuScale Power Corp :
BUZZ - US power utility firms rise on Oracle lift nL3N3UX0NC
** Newmont Corp :
** Gold Fields Ltd :
** Harmony Gold Mining Co Ltd :
** AngloGold Ashanti PLC :
BUZZ - Gold miners gain as bullion hovers near record high nL3N3UX0N2
BUZZ - RBC lifts PT of gold miners on bullish outlook for bullion nL3N3UX0R0
** Ametek Inc :
BUZZ - Barclays begins coverage on Ametek with 'equal weight' rating nL3N3UX0O8
** Synopsys Inc :
BUZZ - Slumps as Q3 results fall short of expectations nL3N3UX0KW
** Greenwich LifeSciences Inc :
BUZZ - Jumps on US FDA's 'fast track' tag for breast cancer therapy nL3N3UX0PU
** Amylyx Pharmaceuticals Inc :
BUZZ - Slips on $175 mln stock offering nL6N3UX0J5
** Tourmaline Bio Inc :
BUZZ - H.C. Wainwright downgrades Tourmaline Bio to 'neutral' after $1.4 billion buyout deal nL3N3UX0RG
** Rocket Companies Inc :
BUZZ - Rises after BofA upgrades to 'buy' on rate-cut tailwinds nL6N3UX0JY
** Travere Therapeutics Inc :
BUZZ - Jumps on FDA's nod to skip advisory panel for kidney disease drug nL3N3UX0T2
(Compiled by Rajarshi Roy and Sanskriti Shekhar)
((Sanskriti.Shekhar@thomsonreuters.com))